Edward Tuttle

1.0k total citations
28 papers, 743 citations indexed

About

Edward Tuttle is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Biomedical Engineering. According to data from OpenAlex, Edward Tuttle has authored 28 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 6 papers in Biomedical Engineering. Recurrent topics in Edward Tuttle's work include Muscle Physiology and Disorders (6 papers), Nuclear Structure and Function (5 papers) and Diabetes Treatment and Management (3 papers). Edward Tuttle is often cited by papers focused on Muscle Physiology and Disorders (6 papers), Nuclear Structure and Function (5 papers) and Diabetes Treatment and Management (3 papers). Edward Tuttle collaborates with scholars based in United States, United Kingdom and Netherlands. Edward Tuttle's co-authors include John Yee, Ginger Smith Carls, Steven V. Edelman, Howard G. Birnbaum, William H. Polonsky, Andrée-Anne Fournier, David S. Bach, Warren M. Jackman, Richard Mortimer and Milena N. Mareva and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Diabetes.

In The Last Decade

Edward Tuttle

26 papers receiving 711 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward Tuttle United States 12 273 186 155 112 87 28 743
Eleanor Lucas United States 10 179 0.7× 360 1.9× 73 0.5× 51 0.5× 71 0.8× 17 940
Aodán Tynan Ireland 8 648 2.4× 109 0.6× 147 0.9× 84 0.8× 87 1.0× 8 917
Nilesh J. Samani United Kingdom 10 97 0.4× 322 1.7× 107 0.7× 48 0.4× 82 0.9× 11 772
Valeria Frighi United Kingdom 11 230 0.8× 91 0.5× 109 0.7× 33 0.3× 124 1.4× 16 584
Andrew T. McAfee United States 14 140 0.5× 107 0.6× 84 0.5× 62 0.6× 153 1.8× 30 637
Immacolata Esposito Italy 9 154 0.6× 195 1.0× 170 1.1× 30 0.3× 99 1.1× 37 634
Gabriella di Mauro Italy 14 118 0.4× 84 0.5× 105 0.7× 35 0.3× 94 1.1× 32 671
Eric Yin Hao Khoo Singapore 15 206 0.8× 89 0.5× 153 1.0× 25 0.2× 53 0.6× 36 618
Nicole Yurgin United States 15 370 1.4× 78 0.4× 96 0.6× 158 1.4× 137 1.6× 33 720
Annemarie M.J. Wassink Netherlands 14 187 0.7× 294 1.6× 48 0.3× 103 0.9× 171 2.0× 18 686

Countries citing papers authored by Edward Tuttle

Since Specialization
Citations

This map shows the geographic impact of Edward Tuttle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Tuttle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Tuttle more than expected).

Fields of papers citing papers by Edward Tuttle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Tuttle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Tuttle. The network helps show where Edward Tuttle may publish in the future.

Co-authorship network of co-authors of Edward Tuttle

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Tuttle. A scholar is included among the top collaborators of Edward Tuttle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Tuttle. Edward Tuttle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Desguerre, Isabelle, Edward Tuttle, Francesco Muntoni, et al.. (2025). Association between exon-skipping therapy with eteplirsen and cardiac outcomes in Duchenne muscular dystrophy. Journal of Neuromuscular Diseases. 13(2). 179–189.
2.
Done, Nicolae, Edward Tuttle, Basil T. Darras, et al.. (2024). Survival among patients receiving eteplirsen for up to 8 years for the treatment of Duchenne muscular dystrophy and contextualization with natural history controls. Muscle & Nerve. 70(1). 60–70. 11 indexed citations
3.
4.
Tuttle, Edward, et al.. (2023). Real-world evidence of eteplirsen treatment effects in patients with Duchenne muscular dystrophy in the USA. Journal of Comparative Effectiveness Research. 12(9). e230086–e230086. 4 indexed citations
5.
6.
7.
Silvestry, Scott, Claudius Mahr, Mark S. Slaughter, et al.. (2020). Cost-Effectiveness of a Small Intrapericardial Centrifugal Left Ventricular Assist Device. ASAIO Journal. 66(8). 862–870. 7 indexed citations
8.
Vekeman, Francis, J. Eric Piña-Garza, Wendy Y. Cheng, et al.. (2019). Development of a classifier to identify patients with probable Lennox–Gastaut syndrome in health insurance claims databases via random forest methodology. Current Medical Research and Opinion. 35(8). 1415–1420. 8 indexed citations
9.
Silvestry, Scott, Claudius Mahr, Mark S. Slaughter, et al.. (2019). Cost-Effectiveness of a Small Intrapericardial Centrifugal LVAD versus Medical Management and Heart Transplantation. The Journal of Heart and Lung Transplantation. 38(4). S132–S132. 2 indexed citations
10.
Gerrits, Charles M., Gautam Sajeev, James Signorovitch, et al.. (2019). Eteplirsen Delays Time to Loss of Ambulation in Patients With Duchenne Muscular Dystrophy Compared With Patients Receiving Standard of Care. Neuropediatrics. 1 indexed citations
11.
McGinnis, Emily, et al.. (2018). Real-World Evidence of Disease Burden in Obese Patients Hospitalized With Acute Bacterial Skin and Skin-Structure Infections. Infectious Diseases in Clinical Practice. 26(6). 333–338. 1 indexed citations
12.
Carls, Ginger Smith, et al.. (2017). Achievement of Glycated Hemoglobin Goals in the US Remains Unchanged Through 2014. Diabetes Therapy. 8(4). 863–873. 166 indexed citations
13.
Piña-Garza, J. Eric, Georgia Montouris, Francis Vekeman, et al.. (2017). Assessment of treatment patterns and healthcare costs associated with probable Lennox–Gastaut syndrome. Epilepsy & Behavior. 73. 46–50. 27 indexed citations
14.
15.
Tuttle, Edward, et al.. (2017). Antibiotic treatment patterns, costs, and resource utilization among patients with community acquired pneumonia: a US cohort study. Hospital Practice. 45(1). 1–8. 15 indexed citations
16.
McGinnis, Emily, et al.. (2016). Characteristics of Patients Hospitalized for Acute Bacterial Skin and Skin Structure Infections (ABSSSI) From 2009 to 2013. Open Forum Infectious Diseases. 3(suppl_1). 5 indexed citations
17.
18.
Chawla, Anita, et al.. (2015). The Expected Net Present Value of Developing Weight Management Drugs in the Context of Drug Safety Litigation. PharmacoEconomics. 33(7). 749–763. 1 indexed citations
19.
Berndt, Ernst R., et al.. (2007). Authorized Generic Drugs, Price Competition, And Consumers’ Welfare. Health Affairs. 26(3). 790–799. 77 indexed citations
20.
Tuttle, Edward. (2004). Dietary cholesterol and atherosclerosis.. PubMed. 7(1). 37–41.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eleanor Lucas Breakdown of academic impact, for papers by Aodán Tynan Breakdown of academic impact, for papers by Nilesh J. Samani Breakdown of academic impact, for papers by Valeria Frighi Breakdown of academic impact, for papers by Andrew T. McAfee Breakdown of academic impact, for papers by Immacolata Esposito Breakdown of academic impact, for papers by Gabriella di Mauro Breakdown of academic impact, for papers by Eric Yin Hao Khoo Breakdown of academic impact, for papers by Nicole Yurgin Breakdown of academic impact, for papers by Annemarie M.J. Wassink
Rankless by CCL
2026